LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Acquisitions Amolyt Pharma has been acquired by multiple prominent pharmaceutical companies such as AstraZeneca, indicating potential collaborative sales opportunities within the acquired companies' networks.

Expansion of Rare Disease Pipeline The acquisition of Amolyt Pharma by AstraZeneca and Imfinzi highlights a focus on rare endocrine diseases, presenting sales potential in offering complementary treatments or expanding market reach.

Tech Stack Utilization Leveraging technologies like WordPress, PHP, and Google Maps could signal opportunities for tech-related sales, such as software integrations or custom development services for endocrinology-focused ventures.

Global Networking Opportunity With a global network in endocrinology, Amolyt Pharma's expertise presents an opening for sales growth through partnerships, joint ventures, or collaboration agreements in international markets.

Phase III Study Progress The launch of a Phase III study for eneboparatide in hypoparathyroidism indicates progress towards potential market readiness, offering sales prospects in providing support services, trial management, or future distribution agreements.

Similar companies to Amolyt Pharma

Amolyt Pharma Tech Stack

Amolyt Pharma uses 8 technology products and services including WordPress, MySQL, Typekit, and more. Explore Amolyt Pharma's tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • Typekit
    Font Scripts
  • Google Maps
    Maps
  • Open Graph
    Miscellaneous
  • Gravatar
    Miscellaneous
  • PHP
    Programming Languages
  • Astra
    Web Platform Extensions

Media & News

Amolyt Pharma's Email Address Formats

Amolyt Pharma uses at least 2 format(s):
Amolyt Pharma Email FormatsExamplePercentage
FLast@alz-pharma.comJDoe@alz-pharma.com
47%
Last@alz-pharma.comDoe@alz-pharma.com
6%
FirstLast@alz-pharma.comJohnDoe@alz-pharma.com
5%
L.First@alz-pharma.comD.John@alz-pharma.com
6%
First-Last@alz-pharma.comJohn-Doe@alz-pharma.com
6%
F.Last@alz-pharma.comJ.Doe@alz-pharma.com
4%
Last.F@alz-pharma.comDoe.J@alz-pharma.com
3%
First_Last@alz-pharma.comJohn_Doe@alz-pharma.com
4%
FirstLa@alz-pharma.comJohnDo@alz-pharma.com
4%
Last.First@alz-pharma.comDoe.John@alz-pharma.com
4%
First_L@alz-pharma.comJohn_D@alz-pharma.com
3%
FL@alz-pharma.comJD@alz-pharma.com
2%
LFirst@alz-pharma.comDJohn@alz-pharma.com
2%
F-Last@alz-pharma.comJ-Doe@alz-pharma.com
2%
Last_First@alz-pharma.comDoe_John@alz-pharma.com
2%
FLast@amolytpharma.comJDoe@amolytpharma.com
100%

Frequently Asked Questions

Where is Amolyt Pharma's headquarters located?

Minus sign iconPlus sign icon
Amolyt Pharma's main headquarters is located at 15, chemin du Saquin, Espace Européen, Building G Ecully, 69130 FR. The company has employees across 2 continents, including EuropeNorth America.

What is Amolyt Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Amolyt Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amolyt Pharma's official website and social media links?

Minus sign iconPlus sign icon
Amolyt Pharma's official website is amolytpharma.com and has social profiles on LinkedIn.

How much revenue does Amolyt Pharma generate?

Minus sign iconPlus sign icon
As of August 2024, Amolyt Pharma's annual revenue reached $7.5M.

What is Amolyt Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Amolyt Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Amolyt Pharma have currently?

Minus sign iconPlus sign icon
As of August 2024, Amolyt Pharma has approximately 58 employees across 2 continents, including EuropeNorth America. Key team members include Chief Business Officer: P. L.Chief Scientific Officer: M. C.Chief Financial Officer: L. A.. Explore Amolyt Pharma's employee directory with LeadIQ.

What industry does Amolyt Pharma belong to?

Minus sign iconPlus sign icon
Amolyt Pharma operates in the Biotechnology Research industry.

What technology does Amolyt Pharma use?

Minus sign iconPlus sign icon
Amolyt Pharma's tech stack includes WordPressMySQLTypekitGoogle MapsOpen GraphGravatarPHPAstra.

What is Amolyt Pharma's email format?

Minus sign iconPlus sign icon
Amolyt Pharma's email format typically follows the pattern of . Find more Amolyt Pharma email formats with LeadIQ.

How much funding has Amolyt Pharma raised to date?

Minus sign iconPlus sign icon
As of August 2024, Amolyt Pharma has raised $139M in funding. The last funding round occurred on Jan 06, 2023 for $139M.

When was Amolyt Pharma founded?

Minus sign iconPlus sign icon
Amolyt Pharma was founded in 2015.
Amolyt Pharma

Amolyt Pharma

Biotechnology ResearchEcully, France51-200 Employees

Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. 

Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. 

Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors.

Section iconCompany Overview

Headquarters
15, chemin du Saquin, Espace Européen, Building G Ecully, 69130 FR
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $139M

    Amolyt Pharma has raised a total of $139M of funding over 9 rounds. Their latest funding round was raised on Jan 06, 2023 in the amount of $139M.

  • $10M

    Amolyt Pharma's revenue is in the range of $10M

Section iconFunding & Financials

  • $139M

    Amolyt Pharma has raised a total of $139M of funding over 9 rounds. Their latest funding round was raised on Jan 06, 2023 in the amount of $139M.

  • $10M

    Amolyt Pharma's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.